top of page

Penn Medicine's Jakub Svoboda describes a CD19 CAR-T that has been armored with IL18 and is being studied for CAR-T relapse patients

He will be presenting final data from a 21 patient NHL cohort at the 2024 ASCO Annual Meeting in June.



コメント


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page